￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What will be the status of midostaurin's domestic launch in 2025?

2026-02-01 22:25:32

Check Details
Cabergoline is a drug from which country?

2026-02-01 22:25:32

Check Details
Molotinib/mometinib shows real improvements in anemia, symptoms and splenic response in myelofibrosis

2026-02-01 22:25:32

Check Details
What is the monthly dosage of Zolbetuximab-Vyloy?

2026-02-01 22:25:32

Check Details
Key information patients need to know: Trametinib’s effectiveness in treating lung cancer

2026-02-01 22:25:32

Check Details
Detailed instructions for dabrafenib/dabrafenib: indications, usage, dosage and precautions

2026-02-01 22:25:32

Check Details
Is Zolbetuximab-Vyloy covered by health insurance?

2026-02-01 22:25:32

Check Details
Detailed instructions for Roprestim/Romigrastim: Indications and Usage

2026-02-01 22:25:32

Check Details
Midostaurin purchasing guide: How should patients obtain it safely?

2026-02-01 22:25:32

Check Details
What is the relationship between Zolbetuximab and Zolbetuximab and vyloy

2026-02-01 22:25:32

Check Details
Cabergoline shelf life analysis: How to store it correctly to ensure efficacy?

2026-02-01 22:25:32

Check Details
Analysis of the relationship between molotinib/momelotinib and momelotinib: key information patients need to know

2026-02-01 22:25:32

Check Details
Category
相关知识